tiprankstipranks
Labixiaoxin Snacks Group Ltd. (HK:1262)
:1262
Hong Kong Market

Labixiaoxin Snacks Group Ltd. (1262) AI Stock Analysis

0 Followers

Top Page

HK:1262

Labixiaoxin Snacks Group Ltd.

(1262)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
HK$4.50
▲(133.16% Upside)
Action:ReiteratedDate:01/28/26
The score is held down primarily by weak financial fundamentals—loss-making operations, high leverage, and concerning cash flow signals. Technicals are supportive in trend terms but are extremely overbought, which adds near-term risk. Valuation is also pressured because the company is unprofitable and dividend support is not available from the provided data.
Positive Factors
Revenue Growth
Sustained top-line growth (13.39% year) reflects expanding demand and market traction for the company’s snack portfolio. Over a 2–6 month horizon this supports capacity utilization, bargaining leverage with suppliers, and the ability to scale marketing or new SKUs to deepen penetration and improve unit economics.
Negative Factors
Negative Profitability
Persistent negative net and operating margins signal structural profitability shortfalls that impair internal funding for growth and debt service. Without meaningful margin improvement through pricing, mix shift, or cost cuts, the business risks needing recurring external financing, weakening long-term stability.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained top-line growth (13.39% year) reflects expanding demand and market traction for the company’s snack portfolio. Over a 2–6 month horizon this supports capacity utilization, bargaining leverage with suppliers, and the ability to scale marketing or new SKUs to deepen penetration and improve unit economics.
Read all positive factors

Labixiaoxin Snacks Group Ltd. (1262) vs. iShares MSCI Hong Kong ETF (EWH)

Labixiaoxin Snacks Group Ltd. Business Overview & Revenue Model

Company Description
Labixiaoxin Snacks Group Limited, an investment holding company, manufactures and sells jelly, confectionary, beverage, and other snack products in the People's Republic of China. It offers jelly snacks, such as fruit-flavored, canned fruit, yogur...
How the Company Makes Money
Labixiaoxin Snacks Group Ltd. generates revenue through multiple key streams, primarily from the sale of its snack products to retailers, wholesalers, and directly to consumers. The company benefits from a diversified product portfolio, which allo...

Labixiaoxin Snacks Group Ltd. Financial Statement Overview

Summary
Despite 13.39% revenue growth (2023–2024), profitability is weak with a -10.79% net margin and negative EBIT/EBITDA margins. Balance sheet risk is elevated due to high leverage (debt-to-equity 2.13) and declining equity. Cash flow quality is a major concern given the lack of positive operating cash flow/free cash flow in 2024 data.
Income Statement
45
Neutral
Balance Sheet
40
Negative
Cash Flow
30
Negative
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue888.87M866.67M764.38M684.26M648.07M508.84M
Gross Profit230.57M234.62M218.94M244.19M224.28M166.54M
EBITDA9.88M-35.72M-46.04M658.00K74.44M108.73M
Net Income-47.29M-93.46M-104.75M-75.33M-65.20M-29.40M
Balance Sheet
Total Assets837.13M793.84M810.91M977.31M1.29B1.53B
Cash, Cash Equivalents and Short-Term Investments47.48M52.50M44.32M71.88M80.57M258.84M
Total Debt461.94M456.40M451.27M512.44M565.59M690.74M
Total Liabilities620.09M579.32M588.35M650.00M887.41M1.06B
Stockholders Equity217.04M214.52M222.56M327.31M402.64M467.84M
Cash Flow
Free Cash Flow-16.58M-34.23M55.42M-4.98M-156.86M-21.57M
Operating Cash Flow37.98M31.53M88.64M15.46M-135.29M-12.47M
Investing Cash Flow-50.91M-65.54M-32.89M55.94M113.42M300.93M
Financing Cash Flow25.54M42.19M-83.31M-80.09M-156.41M-54.46M

Labixiaoxin Snacks Group Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1.93
Price Trends
50DMA
4.08
Negative
100DMA
3.01
Positive
200DMA
2.52
Positive
Market Momentum
MACD
-0.06
Positive
RSI
29.66
Positive
STOCH
12.59
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1262, the sentiment is Neutral. The current price of 1.93 is below the 20-day moving average (MA) of 3.94, below the 50-day MA of 4.08, and below the 200-day MA of 2.52, indicating a neutral trend. The MACD of -0.06 indicates Positive momentum. The RSI at 29.66 is Positive, neither overbought nor oversold. The STOCH value of 12.59 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:1262.

Labixiaoxin Snacks Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
HK$3.55B7.359.86%3.74%11.89%27.80%
73
Outperform
HK$345.00M16.965.40%0.78%5.43%-25.42%
70
Outperform
HK$1.11B7.675.61%10.44%-1.19%-9.05%
65
Neutral
HK$477.25M7.854.61%13.51%2.82%-22.62%
63
Neutral
HK$883.46M-409.980.81%0.00%-1.70%104.41%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
44
Neutral
HK$854.12M52.45-21.92%4.72%79.88%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1262
Labixiaoxin Snacks Group Ltd.
3.64
2.18
149.32%
HK:1583
Qinqin Foodstuffs Group (Cayman) Company
1.10
0.04
3.68%
HK:1285
Jiashili Group Ltd
1.14
0.26
29.55%
HK:1767
TS Wonders Holding Limited
0.35
0.15
75.00%
HK:1837
Natural Food International Holding Ltd.
1.65
1.08
189.47%
HK:2317
Vedan International (Holdings) Ltd.
0.76
0.22
40.74%

Labixiaoxin Snacks Group Ltd. Corporate Events

Labixiaoxin Snacks Group Enters Purchase Agreement with Jinjiang Longquan
Dec 1, 2025
Labixiaoxin Snacks Group Ltd. has entered into a Purchase Agreement with Jinjiang Longquan to buy products from 1 December 2025 to 31 December 2027. This agreement is classified as a continuing connected transaction under the Hong Kong Stock Excha...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 28, 2026